Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 660

1.

Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.

Eom BW, Joo J, Kim YW, Reim D, Park JY, Yoon HM, Ryu KW, Lee JY, Kook MC.

Surgery. 2014 Mar;155(3):408-16. doi: 10.1016/j.surg.2013.08.019. Epub 2013 Nov 25.

PMID:
24287148
2.

Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?

Eom BW, Joo J, Kim YW, Park B, Park JY, Yoon HM, Lee JH, Ryu KW.

Ann Surg Oncol. 2013 Aug;20(8):2669-75. doi: 10.1245/s10434-013-2938-1. Epub 2013 Mar 30.

PMID:
23543195
3.

Clinical characteristics of gastric cancer with metastasis to the lymph node along the superior mesenteric vein (14v).

Masuda TA, Sakaguchi Y, Toh Y, Aoki Y, Harimoto N, Taomoto J, Ikeda O, Ohga T, Adachi E, Okamura T.

Dig Surg. 2008;25(5):351-8. doi: 10.1159/000165382. Epub 2008 Oct 28.

PMID:
18957850
4.

[Significance of No.14v lymph node dissection for advanced gastric cancer undergoing D2 lymphadenectomy].

Liang YX, Liang H, Ding XW, Wang XN, Wu LL, Liu HG, Jiao XG.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jul;16(7):632-6. Chinese.

PMID:
23888444
5.

Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.

Fukunaga T, Hiki N, Kubota T, Nunobe S, Tokunaga M, Nohara K, Sano T, Yamaguchi T.

Ann Surg Oncol. 2013 Aug;20(8):2676-82. doi: 10.1245/s10434-013-2930-9. Epub 2013 May 25.

PMID:
23709054
6.

Reply to questions in response to "improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer".

Eom BW, Joo J, Park B, Kim YW.

Surgery. 2014 Sep;156(3):737-8. doi: 10.1016/j.surg.2014.04.041. Epub 2014 Jul 10. No abstract available.

PMID:
25017137
7.

[Analysis of risk factors associated with metastasis of lymph node along superior mesenteric vein in patients with gastric cancer].

Chen R, Wang H, Wang M, Guan W.

Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Feb;17(2):155-7. Chinese.

PMID:
24577771
8.
9.

Laparoscopic Infrapyloric Area Lymph Node Dissection with No. 14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach.

Chen QY, Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Yang XT.

Ann Surg Oncol. 2016 Mar;23(3):951. doi: 10.1245/s10434-015-4992-3. Epub 2015 Dec 29.

PMID:
26714942
10.

Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.

Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, Nagahori Y, Hosoi H, Takahashi M, Kito F, Shimada H.

Ann Surg Oncol. 2006 May;13(5):659-67. Epub 2006 Mar 14.

PMID:
16538414
11.

Results of D2 gastrectomy for gastric cancer: lymph node chain dissection or multiple node resection?

Zilberstein B, Mucerino DR, Yagi OK, Ribeiro-Junior U, Lopasso FP, Bresciani C, Jacob CE, Coimbra BG, Cecconello I.

Arq Bras Cir Dig. 2012 Jul-Sep;25(3):161-4. English, Portuguese.

12.

[Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].

Wu H, Wang L, He YL, Xu JB, Cai SR, Ma JP, Chen CQ, Zhang XH, Zhan WH.

Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):509-13. Chinese.

PMID:
24257302
13.

Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.

Alatengbaolide, Lin D, Li Y, Xu H, Chen J, Wang B, Liu C, Lu P.

Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.

PMID:
22547011
14.

Indications for pancreaticosplenectomy in advanced gastric cancer.

Chikara K, Hiroshi S, Masato N, Hirotoshi A, Goro M, Hidetaka O.

Hepatogastroenterology. 2001 May-Jun;48(39):908-12.

PMID:
11462954
15.

[Improved survival rate for advanced distal gastric cancer. D2 gastrectomy with additional dissection of lymph nodes on the superior mesenteric artery (14v)].

Franzke T, Jähne J.

Chirurg. 2014 May;85(5):448. doi: 10.1007/s00104-014-2749-3. German. No abstract available.

PMID:
24740177
16.

Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?

Ramacciato G, Aurello P, D'Angelo F, Cicchini C, Sternberg CN.

Hepatogastroenterology. 2000 Sep-Oct;47(35):1470-4.

PMID:
11100379
17.

The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?

Yildirim E, Celen O, Berberoglu U.

J Am Coll Surg. 2001 Jan;192(1):25-37.

PMID:
11192920
18.

Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.

Gunji Y, Suzuki T, Kobayashi S, Hori S, Hayashi H, Shimada H, Matsubara H, Nabeya Y, Ochiai T.

Hepatogastroenterology. 2003 Jul-Aug;50(52):1178-82.

PMID:
12846009
19.

Safety and prognostic impact of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node dissection for lower-third gastric cancer: a propensity score-matched case-control study.

Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Huang CM.

Surg Endosc. 2017 Sep 15. doi: 10.1007/s00464-017-5837-x. [Epub ahead of print]

PMID:
28916893
20.

Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer.

An JY, Pak KH, Inaba K, Cheong JH, Hyung WJ, Noh SH.

Br J Surg. 2011 May;98(5):667-72. doi: 10.1002/bjs.7414. Epub 2011 Feb 4.

PMID:
21294111

Supplemental Content

Support Center